Branched chain ketoacid decarboxylation is defective in:
**Core Concept**
Branched-chain ketoacid dehydrogenase complex (BCKDC) is a key enzyme responsible for the decarboxylation of branched-chain ketoacids, including leucine, isoleucine, and valine. This process is crucial for the metabolism of these essential amino acids. A deficiency in BCKDC leads to a disorder known as maple syrup urine disease (MSUD).
**Why the Correct Answer is Right**
BCKDC is a multienzyme complex that catalyzes the decarboxylation of branched-chain ketoacids through a series of reactions involving multiple enzymes, including E1α, E1β, E2, and E3. The E1α component of BCKDC is specifically targeted in MSUD, leading to the accumulation of toxic branched-chain amino acids and their ketoacids. This results in a characteristic maple syrup-like odor in the urine, hence the name of the disease.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify the enzyme complex responsible for branched-chain ketoacid decarboxylation.
**Option B:** This option is incorrect because it does not accurately identify the enzyme complex or the specific enzyme involved in MSUD.
**Option C:** This option is incorrect because it does not relate to the decarboxylation of branched-chain ketoacids.
**Clinical Pearl / High-Yield Fact**
MSUD is an autosomal recessive disorder, and early diagnosis is crucial to prevent neurological damage. Treatment typically involves a strict diet limiting branched-chain amino acid intake, along with supplements and medications to manage symptoms.
**Correct Answer:** C. Maple syrup urine disease (MSUD) is caused by a deficiency in the branched-chain ketoacid dehydrogenase complex (BCKDC).